This editorial article introduces a renaming of
journal Exosomes and Microvesicles (EXMV) to the Journal
of Circulating Biomarkers with a new editorial scope,
mission and our approach for the upcoming year in
relation to engaging at the international level, the
translational art of the study of exosomes and
microvesicles, and the interface between exosomes and
microvesicles, circulating tumor cells, cell-free circulating
DNA and circulating protein markers in precision
medicine and drug development. There is a slight change
in the members of the Editors in Chief, Editorial Board
and extending collaborations to international societies,
such as the American Society for Exosomes and
Microvesicles (ASEMV)